Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04203303 · ClinicalTrials.gov registry record
Implications of the Human Microbiota for Health and Disease
A clinical trial of Human Microbiota, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- 5,000
- Enrollment target
- 1
- Study location
NCT04203303: Recruiting study of Human Microbiota, sponsored by Mayo Clinic.
NCT04203303 is a study of Human Microbiota that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 5,000 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04203303, a study of Human Microbiota, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- 5,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to advance the understanding of human health and disease as it relates to environmental factors that may affect intestinal and non-intestinal microbiota.
Primary Outcome
compare the relative abundance of specific microorganism groups
Conditions Studied
Interventions
- OTHER Observational
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
| Start Date | 2019-10-03 |
| Est. Completion | 2030-12-31 |
What NCT04203303 shows while recruiting
NCT04203303 is an observational study that tracks outcomes without assigning an intervention. Its 5,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 1 condition, with Human Microbiota appearing as the primary indexed condition, and to 1 intervention - of which Observational is the first listed.
NCT04203303 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT04203303 about?
NCT04203303 is a clinical study titled "Implications of the Human Microbiota for Health and Disease". The purpose of this study is to advance the understanding of human health and disease as it relates to environmental factors that may affect intestinal and non-intestinal microbiota.
What is the current status of trial NCT04203303?
This trial is currently recruiting. The enrollment target is 5,000 participants. The study started on 2019-10-03. Estimated completion is 2030-12-31.
What conditions does trial NCT04203303 study?
This clinical trial studies the following conditions: Human Microbiota.
What interventions are being tested in trial NCT04203303?
The interventions under investigation include: Observational (OTHER).
Who is sponsoring clinical trial NCT04203303?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04203303 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00060541 · 5,000 participants
Evaluation and Treatment of Neurosurgical Disorders
- NCT00575081 · 5,000 participants
Physiological Brain Atlas Development
- NCT00736749 · 5,000 participants
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
- NCT00900198 · 5,000 participants
Collection of Tissue Samples for Cancer Research
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI